Julian W. Sacre

Julian W. Sacre

Auto-generated profile, based on publicly available information

Julian W. Sacre

Baker Heart and Diabetes Institute Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
KOKatherine Ogurtsova
Katherine Ogurtsova
LGLeonor Guariguata
Leonor Guariguata
Noel Christopher BarengoNoel Christopher Barengo
Noel Christopher Barengo
PRPaz Lopez-Doriga Ruiz
Paz Lopez-Doriga Ruiz
JSJulian W. Sacre
Julian W. Sacre
DMDianna Magliano
Dianna Magliano

13 April 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
RLRobyn N. Larsen
Robyn N. Larsen
PSParneet Sethi
Parneet Sethi
JSJulian W. Sacre
Julian W. Sacre
NSNora E. Straznicky
Nora E. Straznicky
DDDavid W. Dunstan
David W. Dunstan
OBJECTIVE: To determine whether interrupting prolonged sitting with brief bouts of light-intensity walking (LW) or simple resistance activities (SRA) improves postprandial cardiometabolic risk markers in adults with type 2 diabetes (T2D).RESEARCH DESIGN AND METHODS: In a randomized crossover trial, 24 inactive overweight/obese adults with T2D (14 men 62 ± 6 years old) underwent the following 8-h conditions on three separate days (with 6–14 days washout): uninterrupted sitting (control) (SIT), sitting plus 3-min bouts of LW (3.2 km · h−1) every 30 min, and sitting plus 3-min bouts of SRA (half-squats, calf raises, gluteal contractions, and knee raises) every 30 min. Standardized meals were consumed during each condition. Incremental areas under the curve (iAUCs) for glucose, insulin, C-peptide, and triglycerides were compared between conditions.RESULTS: Compared with SIT, both activity-break conditions significantly attenuated iAUCs for glucose (SIT mean 24.2 mmol · h · L−1 [95% CI 20.4–28.0] vs. LW 14.8 [11.0–18.6] and SRA 14.7 [10.9–18.5]), insulin (SIT 3,293 pmol · h · L−1 [2,887–3,700] vs. LW 2,104 [1,696–2,511] and SRA 2,066 [1,660–2,473]), and C-peptide (SIT 15,641 pmol · h · L−1 [14,353–16,929] vs. LW 11,504 [10,209–12,799] and SRA 11,012 [9,723–12,301]) (all P < 0.001). The iAUC for triglycerides was significantly attenuated for SRA (P < 0.001) but not for LW (SIT 4.8 mmol · h · L−1 [3.6–6.0] vs. LW 4.0 [2.8–5.1] and SRA 2.9 [1.7–4.1]).CONCLUSIONS: Interrupting prolonged sitting with brief bouts of LW or SRA attenuates acute postprandial glucose, insulin, C-peptide, and triglyceride responses in adults with T2D. With poor adherence to structured exercise, this approach is potentially beneficial and practical.

1 December 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
JSJulian W. Sacre
Julian W. Sacre
RLRobyn N. Larsen
Robyn N. Larsen
NSNora E. Straznicky
Nora E. Straznicky
PSParneet Sethi
Parneet Sethi
DDDavid W. Dunstan
David W. Dunstan
Prolonged sitting is increasingly recognized as a ubiquitous cardiometabolic risk factor, possibly distinct from lack of physical exercise. We examined whether interrupting prolonged sitting with brief bouts of light-intensity activity reduced blood pressure (BP) and plasma noradrenaline in type 2 diabetes (T2D). In a randomized crossover trial, 24 inactive overweight/obese adults with T2D (14 men; mean ± SD; 62 ± 6 years) consumed standardized meals during 3 × 8 h conditions: uninterrupted sitting (SIT); sitting + half-hourly bouts of walking (3.2 km/h for 3-min) (light-intensity walking); and sitting + half-hourly bouts of simple resistance activities for 3 min (SRAs), each separated by 6–14 days washout. Resting seated BP was measured hourly (mean of three recordings, ≥20-min postactivity). Plasma noradrenaline was measured at 30-min intervals for the first hour after meals and hourly thereafter. Compared with SIT, mean resting SBP and DBP were significantly reduced (P < 0.001) for both light-intensity walking (mean ± SEM; −14 ± 1/−8 ± 1 mmHg) and SRA (−16 ± 1/−10 ± 1 mmHg), with a more pronounced effect for SRA (P < 0.05 versus light-intensity walking). Similarly, mean plasma noradrenaline was significantly reduced for both light-intensity walking (−0.3 ± 0.1 nmol/l) and SRA (−0.6 ± 0.1 nmol/l) versus SIT, with SRA lower than light-intensity walking (P < 0.05). Mean resting heart rate was lowered by light-intensity walking (−3 ± 1 bpm; P < 0.05), but not SRA (−1 ± 1 bpm). Interrupting prolonged sitting with brief bouts of light-intensity walking or SRA reduces resting BP and plasma noradrenaline in adults with T2D, with SRA being more effective. Given the ubiquity of sedentary behaviors and poor adherence to structured exercise, this approach may have important implications for BP management in patients with T2D.

1 November 2011 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
CJChristine Jellis
Christine Jellis
JWJeremy Wright
Jeremy Wright
DKDominic Kennedy
Dominic Kennedy
JSJulian Sacre
Julian Sacre
CJCarly Jenkins
Carly Jenkins
TMThomas H. Marwick
Thomas H. Marwick
Background—: Metabolic and vascular disturbances contribute to diabetic cardiomyopathy, but the role of interstitial fibrosis in early disease is unproven. We sought to assess the relationship between imaging markers of diffuse fibrosis and myocardial dysfunction and to link this to possible causes of early diabetic cardiomyopathy. Methods and Results—: Hemodynamic and metabolic data were measured in 67 subjects with type 2 diabetes mellitus (age 60±10 years) with no cardiac symptoms. Myocardial function was evaluated with standard echocardiography and myocardial deformation; ischemia was excluded by exercise echocardiography. Calibrated integrated backscatter was calculated from parasternal long-axis views. T1 mapping was performed after contrast with a modified Look-Locker technique using saturation recovery images. Amino-terminal propeptides of procollagens type I and III, as well as the carboxy-terminal propeptide of procollagen type I, were assayed to determine collagen turnover. Subjects with abnormal early diastolic tissue velocity (E m ) had shorter postcontrast T1 values ( P =0.042) and higher calibrated integrated backscatter ( P =0.007). They were heavier ( P =0.003) and had worse exercise capacity ( P <0.001), lower insulin sensitivity ( P =0.003), and blunted systolic tissue velocity ( P =0.05). Postcontrast T1 was associated with diastolic dysfunction (E m r =0.28, P =0.020; E/E m r =−0.24, P =0.049), impaired exercise capacity ( r =0.30, P =0.016), central adiposity ( r =−0.26, P =0.046), blood pressure (systolic r =−0.30, P =0.012; diastolic r =−0.49, P <0.001), and insulin sensitivity ( r =0.30, P =0.037). The association of T1 with E/E m (β=−0.31, P =0.017) was independent of blood pressure and metabolic disturbance. Amino-terminal propeptide of procollagens type III was linked to diastolic dysfunction (E m r =−0.32, P =0.008) and calibrated integrated backscatter ( r =0.30, P =0.015) but not T1 values. Conclusions—: The association between myocardial diastolic dysfunction, postcontrast T1 values, and metabolic disturbance supports that diffuse myocardial fibrosis is an underlying contributor to early diabetic cardiomyopathy.

9 December 2016 in Diabetologia
Verified
Journal Article
Closed access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
JBJennifer M. Blankenship
Jennifer M. Blankenship
RLRobyn N. Larsen
Robyn N. Larsen
JSJulian W. Sacre
Julian W. Sacre
PSParneet Sethi
Parneet Sethi
DDDavid W. Dunstan
David W. Dunstan

1 December 2010 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JSJulian W. Sacre
Julian W. Sacre
BFBennett Franjic
Bennett Franjic
CJChristine L. Jellis
Christine L. Jellis
CJCarly Jenkins
Carly Jenkins
JCJeff S. Coombes
Jeff S. Coombes
TMThomas H. Marwick
Thomas H. Marwick